About 10 percent of U.S. Medicare patients -- including cancer survivors -- do not take their medication because it is too expensive, Harvard researchers found. Dr. Larissa Nekhlyudov and colleagues from Harvard Medical School show cost-related medication non-adherence -- skipping pills to make the medicine last longer, and not filling in a prescription because it is too expensive -- is common among seniors. The researchers analyzed data from the 2005 Medicare Current Beneficiary Survey and Medicare claims. Nekhlyudov and the research team found no differences in the rate of cost-related non-adherence between cancer survivors and those without cancer. Six percent of cancer survivors and 9 percent of those without cancer said they spent less on basic needs -- such as food and heat -- so they could afford medicines. More than half used other cost-saving measures, including taking generic medications, requesting free samples and comparing pharmacy prices before buying drugs, Nekhlyudov says. "As the number of cancer survivors continues to increase and get older, the findings of our study enhance our understanding of the potential barriers to effective treatment of their non-cancer co-morbidities," Nekhlyudov says. The findings are published in the Journal of Cancer Survivorship.
GMT 10:31 2018 Tuesday ,13 November
Russian police uproot 70 underground drug labs in past six monthsGMT 16:32 2018 Tuesday ,06 November
Rwanda aims to achieve universal access to clean water by 2024GMT 16:57 2018 Sunday ,04 November
Palestinian women witness higher cure rate of breast cancerGMT 13:11 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 10:44 2018 Tuesday ,23 October
Scientists find microplastics in human stool for first timeGMT 09:18 2018 Tuesday ,23 October
US judge upholds Monsanto weedkiller cancer verdict, reduces payoutGMT 14:22 2018 Friday ,19 October
Birth spacing ‘improving health of Omani women’GMT 15:40 2018 Monday ,15 October
Pakistani president launches nationwide anti-measles driveMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor